Dyskinesia, Drug-Induced

Known as: Dyskinesia, Drug Induced, drug dyskinesias induced, Dyskinesia, Drug-Induced [Disease/Finding] 
Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of… (More)

Topic mentions per year

Topic mentions per year

1944-2017
050019442016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
The pharmacological treatment of Parkinson's disease (PD) is limited to dopamine agonists and anti-cholinergic drugs that do not… (More)
Is this relevant?
Review
2015
Review
2015
Primary ciliary dyskinesia (PCD) is a ciliopathy, but represents the sole entity from this class of disorders that results from… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
In patients with Parkinson's disease, the therapeutic efficacy of L-DOPA medication is gradually lost over time, and abnormal… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To report the autoantigens of a new category of treatment-responsive paraneoplastic encephalitis. METHODS Analysis of… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The molecular basis of L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia (LID), one of the major hindrances in the current… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Peak-dose dyskinesias are abnormal movements that usually occur 1 h after oral administration of levodopa, and often complicate… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Long-term treatment with the dopamine precursor levodopa (L-DOPA) induces dyskinesia in Parkinson's disease (PD) patients. We… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
In an attempt to define clinically relevant models of akinesia and dyskinesia in 6-hydroxydopamine (6-OHDA)-lesioned rats, we… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND There is debate about whether the initial treatment for patients with Parkinson's disease should be levodopa or a… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Rats sustaining unilateral near-complete 6-hydroxydopamine lesions of the mesostriatal dopamine pathway received daily injections… (More)
Is this relevant?